Clinical Trials | Novartis

Media Release
Nov 20, 2023
Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASH
Media Release
Oct 07, 2021
Novartis to present broad range of portfolio data at ECTRIMS, reinforcing long-standing commitment to people living with multiple sclerosis
Media Release
Sep 23, 2020
Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program
Media Release
May 27, 2021
Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19
Media Release
Jun 02, 2021
Novartis presents positive Phase III results from JUNIPERA study supporting Cosentyx® as a potential treatment in a JIA population at EULAR 2021
Media Release
Dec 12, 2019
Novartis Kisqali® data show superior overall survival compared to fulvestrant and consistent efficacy across advanced breast cancer patient subgroups in MONALEESA-3
Story
Jun 04, 2019
Toward improving the health and longevity of transplanted organs
Story
Oct 01, 2018
Researchers boost understanding of T-cell therapy in blood cancer
Story
May 24, 2019
Cancer research drives breast cancer treatment forward
Story
Nov 01, 2019
Can data from a heart disease trial lead to a potential cancer treatment?
Story
Apr 20, 2020
Going the extra mile to keep clinical trials on track during the COVID-19 pandemic
Story
Jan 11, 2021
Turning the sound up on patient voices in lung cancer research and development